Clinical trials

Condition   Drug Name  
Study Col-118 in erythema
Design Randomized; Double-blind; Multicenter
Patients 110
Treatment Regimen Col-118 top. x 28 d; Placebo
Conclusions A phase II study demostrated that col-118 was effective in reducing the Clinical Erythema Assessement scores
Reference(s) CollaGenex Pharmaceuticals announces highly positive results of phase 2 dose-finding trial of Col-118 for the treatment of erythema
CollaGenex Pharmaceuticals Press Release 2007